1. Home
  2. AYTU vs AQMS Comparison

AYTU vs AQMS Comparison

Compare AYTU & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.33

Market Cap

20.5M

Sector

Health Care

ML Signal

HOLD

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$6.48

Market Cap

20.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AYTU
AQMS
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
20.5M
20.9M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
AYTU
AQMS
Price
$2.33
$6.48
Analyst Decision
Strong Buy
Buy
Analyst Count
3
1
Target Price
$9.33
$12.00
AVG Volume (30 Days)
52.7K
162.4K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$63,696,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$47.30
$550.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$3.37
52 Week High
$2.82
$39.40

Technical Indicators

Market Signals
Indicator
AYTU
AQMS
Relative Strength Index (RSI) 60.88 43.74
Support Level $2.05 $6.93
Resistance Level $2.39 $7.61
Average True Range (ATR) 0.10 0.59
MACD 0.03 -0.03
Stochastic Oscillator 78.57 0.00

Price Performance

Historical Comparison
AYTU
AQMS

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: